About FIT Biotech
FIT Biotech Oyj Plc (formerly Finnish Immunotechnology Oy) was founded in 1995 as an R&D biotechnology company concentrating on the development of vaccines and gene transport technology. FIT Biotech's headquarters are located in Tampere, Finland, where it also has a cGMP approved production facility. In addition, the company has a research facility in Tartu, Estonia.
FIT Biotech's long-term vision is to continue developing selected vaccines and gene therapies based on its proprietary gene delivery technology (GTU®). FIT Biotech plans to become a globally renowned name in the fields of vaccines and DNA delivery through its own research and product acquisitions.
- Focus : Manufacturer
- Industry : Biotechnology
Product portfolio of FIT Biotech
Similar companies
News about FIT Biotech
Here you will find FIT Biotech Oyj Plc.
See the theme worlds for related content
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
Topic world Antibodies
Antibodies are specialized molecules of our immune system that can specifically recognize and neutralize pathogens or foreign substances. Antibody research in biotech and pharma has recognized this natural defense potential and is working intensively to make it therapeutically useful. From monoclonal antibodies used against cancer or autoimmune diseases to antibody-drug conjugates that specifically transport drugs to disease cells - the possibilities are enormous
